• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov19
B. Riley Gives Nuvation a Buy Rating with a $12 Price Target
16:03
Nov17
Nuvation Bio Announces Positive Phase 2 Results for Safusidenib and Plans for Phase 3 Trial
22:57
Nov4
Werber Analyzes Healthcare Stocks and Provides Analyst Consensus
03:46
Nuvation Bio released FY2025 9 Months Earnings on November 3 After-Market EST, with actual revenue of USD 7.917 M and EPS of USD -0.3331
00:00
Nuvation Bio released FY2025 Q3 earnings on November 3 After-Market EST, actual revenue USD 13.12 M (forecast USD 6.862 M), actual EPS USD -0.1629 (forecast USD -0.17)
00:00
Nov3
Nuvation Bio Announces Significant Progress in Oncology Portfolio
21:44

Schedules & Filings

Schedules
Filings
Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 13.12 M, Net Income -55.79 M, EPS -0.1629

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.833 M, Net Income -59.01 M, EPS -0.1731

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 3.084 M, Net Income -53.24 M, EPS -0.16

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
WSHP
174.110
+427.61%
+141.110
JGH.RT
0.0055
+175.00%
+0.004
BACCR
0.3905
+77.50%
+0.171
FRGT
1.155
+74.97%
+0.495
SEMR
11.790
+74.41%
+5.030
PGACR
0.3400
+54.48%
+0.120
NUVB
7.198
+49.96%
+2.400
SSEAR
0.2999
+42.81%
+0.090
SGBX
4.840
+41.94%
+1.430
KZIA
8.060
+39.92%
+2.300
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy